Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Access and reimbursement pathways for digital health solutions and in vitro diagnostic devices: Current scenario and challenges

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Mantovani et al. reviewed the current regulatory and reimbursement approaches adopted for digital therapeutics (DTx) and in-vitro diagnostics (IVDs) in the US, Europe, and Australia. In Europe, authors offer an overview of reimbursement pathways in France, Germany and the United Kingdom for digital and in-vitro diagnostic technologies.

Access the full-text article here.